in Short

Rwanda: BioNTech vaccines production to kick start In 24 months

Rwanda will start production of vaccines in two years. According to the Ministry of Health, the construction of the vaccine production plant will start in June, this year. It is expected to produce at least 50 million vaccine doses annually.

The period for local production of mRNA-based vaccines was announced after Rwanda inked a deal with Germany biotechnology giant, BioNTech to establish the first mRNA-based vaccines manufacturing plant that is estimated to cost $116m last year in October 2021.

Découvrez le dernier ANAmag intitulé « Diaspora, une expertise à valoriser » conçu en partenariat avec Expertise France

Articles similaires

Bouton retour en haut de la page